[Multiple palmoplantar keratoses, basaliomas and porocarcinomas after arsenic therapy].
Junge
J
J
Hautklinik, Universität Heidelberg.
Moll
I
I
D018250:Acrospiroma / Q000139:chemically induced* / Q000473:pathology; D000368:Aged; D018053:Arsenites / Q000008:administration & dosage / Q000009:adverse effects*; D014408:Biomarkers, Tumor / Q000032:analysis; D001706:Biopsy; D002280:Basal Cell Carcinoma / Q000139:chemically induced* / Q000473:pathology; D003937:Diagnosis, Differential; D006801:Humans; D007633:Keratins / Q000032:analysis; D007645:Keratoderma, Palmoplantar / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D009378:Neoplasms, Multiple Primary / Q000139:chemically induced* / Q000473:pathology; D017680:Potassium Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D011230:Precancerous Conditions / Q000139:chemically induced* / Q000473:pathology; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000139:chemically induced* / Q000473:pathology
D018053:Arsenites; D014408:Biomarkers, Tumor; D017680:Potassium Compounds; C009003:potassium arsenite solution; D007633:Keratins